This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.93% per year. These returns cover a period from January 1, 1988 through March 2, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
medical-devices: Archive
Here's Why You Should Add Hinge Health Stock to Your Portfolio Now
by Zacks Equity Research
HNGE pairs rapid growth and AI-driven efficiency with rising execution risks as 2026 slowdown, margin pressure, and engagement reliance cloud outlook.
ALGNNegative Net Change CAHPositive Net Change VEEVPositive Net Change HNGEPositive Net Change
medical medical-devices
Intuitive Surgical Under Pressure in China: Can It Defend Its Position?
by Indrajit Bandyopadhyay
ISRG faces rising pricing pressure in China as local rivals gain ground, but its ecosystem, local manufacturing and disciplined pricing aim to defend its position.
ISRGNegative Net Change STXSPositive Net Change GMEDPositive Net Change
medical medical-devices
Reasons to Hold HealthEquity Stock in Your Portfolio for Now
by Zacks Equity Research
HQY rides on strong HSA growth, AI-driven efficiency gains and solid Q4 results, though data security threats remain a key risk.
GMEDPositive Net Change HQYPositive Net Change NVSTNegative Net Change BTSGPositive Net Change
medical medical-devices
Cardinal Health Expands Ac-225 Capacity to Boost Cancer Therapies
by Zacks Equity Research
CAH expands Ac-225 capacity, boosting its role in radiopharma as rising clinical demand and future cancer therapy commercialization drive growth.
CAHPositive Net Change GMEDPositive Net Change NVSTNegative Net Change BTSGPositive Net Change
medical medical-devices
Implied Volatility Surging for Fortrea Holdings Stock Options
by Zacks Equity Research
Investors need to pay close attention to Fortrea Holdings stock based on the movements in the options market lately.
FTRENegative Net Change
medical medical-devices
Vaso Stock Declines Post Q4 Earnings Despite Revenue Growth
by Zacks Equity Research
VASO posts steady fourth-quarter 2025 revenues but weaker earnings as higher costs and impairment charges weigh, though core segments and margins show resilience.
VASONegative Net Change
earnings medical medical-devices
Here's Why You Should Add NeuroPace Stock to Your Portfolio Now
by Zacks Equity Research
NPCE rides strong RNS adoption and AI innovation, but near-term profitability faces pressure as IGE expansion and revenue contribution remain uncertain.
CAHPositive Net Change PAHCPositive Net Change NPCEPositive Net Change GEHCNegative Net Change
medical medical-devices
MMSI Expands Oncology Offering With View Point Medical Acquisition
by Zacks Equity Research
Merit Medical acquires View Point Medical for $140M, boosting tumor detection tech and expanding its oncology portfolio with advanced localization solutions.
CAHPositive Net Change MMSINegative Net Change PAHCPositive Net Change INSPPositive Net Change
medical medical-devices
Should You Continue to Retain Bruker Stock in Your Portfolio?
by Zacks Equity Research
BRKR faces macro and currency headwinds, but strong BSI Nano growth, AI-driven demand and BioSpin innovations support its long-term outlook.
ISRGNegative Net Change GMEDPositive Net Change BRKRPositive Net Change NVSTNegative Net Change
medical medical-devices
TMO Stock May Gain From the Rollout of Gibco CHOvantage GS CLD Kit
by Zacks Equity Research
Thermo Fisher may gain as it unveils its Gibco CHOvantage GS CLD Kit to speed biologics development, cut costs and boost cell culture growth.
TMONegative Net Change GMEDPositive Net Change NVSTNegative Net Change BTSGPositive Net Change
medical medical-devices